| 產(chǎn)品編號(hào) | 圖片 | CAS No. | 名稱及描述 | 規(guī)格 | 價(jià)格 | 分子式 | 快速訂購 |
|---|---|---|---|---|---|---|---|
| GC39250-100mg |
|
1087-26-9 |
Hexyl gallate - Glpbio |
0 | 需詢價(jià) | C13H18O5 | |
| GC39250-10mM (in 1mL DMSO) |
|
1087-26-9 |
Hexyl gallate - Glpbio |
0 | 需詢價(jià) | C13H18O5 | |
| GC39249-100mg |
|
109351-33-9 |
(S)-Terazosin - Glpbio |
0 | 需詢價(jià) | C19H25N5O4 | |
| GC39249-50mg |
|
109351-33-9 |
(S)-Terazosin - Glpbio |
0 | 需詢價(jià) | C19H25N5O4 | |
| GC39249-10mg |
|
109351-33-9 |
(S)-Terazosin - Glpbio |
0 | 需詢價(jià) | C19H25N5O4 | |
| GC39249-5mg |
|
109351-33-9 |
(S)-Terazosin - Glpbio |
0 | 需詢價(jià) | C19H25N5O4 | |
| GC39249-10mM (in 1mL DMSO) |
|
109351-33-9 |
(S)-Terazosin - Glpbio |
0 | 需詢價(jià) | C19H25N5O4 | |
| GC39248-100mg |
|
1093861-60-9 |
Afoxolaner - Glpbio |
0 | 需詢價(jià) | C26H17ClF9N3O3 | |
| GC39248-50mg |
|
1093861-60-9 |
Afoxolaner - Glpbio |
0 | 需詢價(jià) | C26H17ClF9N3O3 | |
| GC39248-25mg |
|
1093861-60-9 |
Afoxolaner - Glpbio |
0 | 需詢價(jià) | C26H17ClF9N3O3 | |
| GC39248-10mg |
|
1093861-60-9 |
Afoxolaner - Glpbio |
0 | 需詢價(jià) | C26H17ClF9N3O3 | |
| GC39248-10mM (in 1mL DMSO) |
|
1093861-60-9 |
Afoxolaner - Glpbio |
0 | 需詢價(jià) | C26H17ClF9N3O3 | |
| GC39247-250mg |
|
115819-92-6 |
N-Hydroxypipecolic acid - Glpbio |
0 | 需詢價(jià) | C6H11NO3 | |
| GC39247-100mg |
|
115819-92-6 |
N-Hydroxypipecolic acid - Glpbio |
0 | 需詢價(jià) | C6H11NO3 | |
| GC39247-50mg |
|
115819-92-6 |
N-Hydroxypipecolic acid - Glpbio |
0 | 需詢價(jià) | C6H11NO3 | |
| GC39247-10mg |
|
115819-92-6 |
N-Hydroxypipecolic acid - Glpbio |
0 | 需詢價(jià) | C6H11NO3 | |
| GC39247-5mg |
|
115819-92-6 |
N-Hydroxypipecolic acid - Glpbio |
0 | 需詢價(jià) | C6H11NO3 | |
| GC39246-100mg |
|
1198151-75-5 |
Vapendavir diphosphate - Glpbio |
0 | 需詢價(jià) | C21H32N4O11P2 | |
| GC39246-50mg |
|
1198151-75-5 |
Vapendavir diphosphate - Glpbio |
0 | 需詢價(jià) | C21H32N4O11P2 | |
| GC39246-10mg |
|
1198151-75-5 |
Vapendavir diphosphate - Glpbio |
0 | 需詢價(jià) | C21H32N4O11P2 | |
小泰
|
010-60710855
|